A galanin(2-11) analogue specific for GalR2
Johan Runesson, Kristin Karlsson, Ülo Langel
Abstract
Johan Runesson, Kristin Karlsson, Ülo Langel
Abstract
The neuropeptide galanin family currently consists of four members, namely galanin, galanin-message-associated peptide (GMAP), galanin-like peptide (GALP) and alarin. Galanin has been shown to influence several physiological processes including cognition, affective behavior, nerve injury, Alzheimer’s disease, neuroregeneration, seizures, feeding, and hormone release. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family. The regionally specific expression of the galanin receptors (GalR1-3) suggests different physiological roles, a feature which mostly remains unexplored due to the lack of stable, selective and potent ligands acting on the galanin receptor subtypes. The introduction of galanin(2-11) as a GalR2 selective ligand was an important advance in the galanin field. Unfortunately, later publications described that galanin(2-11) also binds with similar affinity to GalR3, a critical limitation when delineating the interplay between galanin receptor subtypes. Even so, galanin(2-11) has been given extensive attention and been used in numerous study as a non-GalR1 ligand. We now introduce an analogue of galanin(2-11) that combines the GalR2 selective binding, comparable with the published M1145 with the small size of galanin(2-11). Utilizing this true GalR2 selective ligand will help to define the role GalR2 in general and especially for already published studies that has been exploit galanin(2-11).
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The neuropeptide galanin family currently consists of four members, namely galanin, galanin-message-associated peptide (GMAP), galanin-like peptide (GALP) and alarin. Galanin has been shown to influence several physiological processes including cognition, affective behavior, nerve injury, Alzheimer’s disease, neuroregeneration, seizures, feeding, and hormone release. The co-localization with other neuromodulators and the distinct up-regulation during and after pathological disturbances has drawn attention to this neuropeptide family. The regionally specific expression of the galanin receptors (GalR1-3) suggests different physiological roles, a feature which mostly remains unexplored due to the lack of stable, selective and potent ligands acting on the galanin receptor subtypes. The introduction of galanin(2-11) as a GalR2 selective ligand was an important advance in the galanin field. Unfortunately, later publications described that galanin(2-11) also binds with similar affinity to GalR3, a critical limitation when delineating the interplay between galanin receptor subtypes. Even so, galanin(2-11) has been given extensive attention and been used in numerous study as a non-GalR1 ligand. We now introduce an analogue of galanin(2-11) that combines the GalR2 selective binding, comparable with the published M1145 with the small size of galanin(2-11). Utilizing this true GalR2 selective ligand will help to define the role GalR2 in general and especially for already published studies that has been exploit galanin(2-11).
Key concepts: Galanin, Galanin receptor, Neuropeptide, Internal medicine, Endocrinology, Biology, Receptor, Neuroscience